Screening for the high-risk foot of ulceration: Tests of somatic and autonomic nerve function

Current Diabetes Reports

Volumn 11, Issue 4, 2011, Pages 294-301

  Argiana, Vasiliki ^a   Eleftheriadou, Ioanna ^a   Tentolouris, Nicholas ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Autonomic nerve function; Autonomic neuropathy; Diabetes; Foot ulceration; Peripheral neuropathy; Somatic nerve function; Tests

Indexed keywords

ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MONOFILAMENT TESTING; NERVE CONDUCTION; NERVE FUNCTION; NEUROLOGIC EXAMINATION; NEUROPATHY DISABILITY SCORE; PREDICTIVE VALUE; REPRODUCIBILITY; RISK ASSESSMENT; SCORING SYSTEM; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SWEAT GLAND DISEASE; SYMPATHETIC FUNCTION; VIBRATION PERCEPTION THRESHOLD;

AUTONOMIC PATHWAYS; CROSS-SECTIONAL STUDIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FOOT ULCER; HUMANS;

EID: 80051577110     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-011-0192-0     Document Type: Article

References (53)

1. L Vileikyte 2001 Diabetic foot ulcers: a quality of life issue Diabetes Metabol Res Rev 17 246 249 10.1002/dmrr.216 1:STN:280:DC%2BD3MvpsFChsA%3D%3D (Pubitemid 32821657)
2. AJ Boulton L Vileikyte G Ragnarson-Tennvall J Apelqvist 2005 The global burden of diabetic foot disease Lancet 366 1719 1724 16291066 10.1016/S0140-6736(05)67698-2 (Pubitemid 41587452)
3. Gibbons GM, Eliopoulos GM. Infection of the diabetic foot. In: Kozak GP, Campbell DR, Frykberg RG, Habershaw GM, editors. Management of diabetic foot problems. Philadelphia: Saunders; 1995. p. 121-9.
4. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, editors. Diabetes in America. Washington: U.S.Govt. Printing Office; 1995. p. 409-28.
5. SD Ramsey K Newton D Blough, et al. 1999 Incidence, outcomes, and cost of foot ulcers in patients with diabetes Diabetes Care 22 382 387 10097914 10.2337/diacare.22.3.382 1:STN:280:DyaK1M7psl2rtQ%3D%3D (Pubitemid 29106890)
6. OI Siitonen LK Niskanen M Laakso JT Siitonen K Pyorala 1993 Lower-extremity amputations in diabetic and nondiabetic patients: a population-based study in eastern Finland Diabetes Care 16 16 20 8422771 10.2337/diacare.16.1.16 1:STN:280:DyaK3s7jslKntw%3D%3D (Pubitemid 23013819)
7. C Trautner B Haastert G Giani M Berger 1996 Incidence of lower limb amputations and diabetes Diabetes Care 19 1006 1009 8875099 10.2337/diacare.19. 9.1006 1:STN:280:DyaK2s%2FivFSrtQ%3D%3D (Pubitemid 26301241)
8. AJ Boulton AI Vinik JC Arezzo V Bril EL Feldman R Freeman, et al. 2005 American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 956 962 15793206 10.2337/diacare.28.4.956 (Pubitemid 40434506)
9. HE Resnick EA Carter R Lindsay SJ Henly FK Ness TK Welty, et al. 2004 Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study Diabetes Care 27 1286 1293 15161777 10.2337/diacare.27.6.1286 (Pubitemid 38679972)
10. IR Hambleton R Jonnalagadda CR Davis HS Fraser N Chaturvedi AJ Hennis 2009 All-cause mortality after diabetes-related amputation in Barbados: a prospective case-control study Diabetes Care 32 306 307 18984775 10.2337/dc08-1504
11. AJ Boulton 1998 Lowering the risk of neuropathy, foot ulcers and amputations Diabet Med 15 S57 S59 9868994 10.1002/(SICI)1096-9136(1998120)15: 4+3.3.CO;2-4
12. AJ Boulton DG Armstrong SF Albert RG Frykberg R Hellman MS Kirkman, et al. 2008 Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists Diabetes Care 31 1679 1685 18663232 10.2337/dc08-9021 A report of the task force of the American Diabetes Association and the American Association of Clinical Endocrinologists on risk assessment and foot examination in patients with diabetes
13. DG Armstrong 2000 The 10-g monofilament: the diagnostic divining rod for the diabetic foot Diabetes Care 23 887 10895835 10.2337/diacare.23.7.887 1:STN:280:DC%2BD3M%2FhtlGhug%3D%3D (Pubitemid 30480012)
14. H Pham DG Armstrong C Harvey LB Harkless JM Giurini A Veves 2000 Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial Diabetes Care 23 606 611 10834417 10.2337/diacare.23.5.606 1:STN:280:DC%2BD3cvitVSlsw%3D%3D (Pubitemid 30321538)
15. CA Abbott AL Carrington H Ashe S Bath LC Every J Griffiths, et al. 2002 The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort Diabet Med 19 377 384 12027925 10.1046/j.1464-5491.2002.00698.x 1:STN:280:DC%2BD383ovVanug%3D%3D (Pubitemid 34534212)
16. N Singh DG Armstrong BA Lipsky 2005 Preventing foot ulcers in patients with diabetes JAMA 293 217 228 15644549 10.1001/jama.293.2.217 1:CAS:528:DC%2BD2MXktVyqtA%3D%3D (Pubitemid 40095873)
17. Crawford F, McCowan C, Dimitrov BD, Woodburn J, Wylie GH, Booth E, Leese GP, Bekker HL, Kleijnen J, Fahey T: The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM 2010, Epub ahead of print.
18. LS Tan 2010 The clinical use of the 10g monofilament and its limitations: a review Diabetes Res Clin Pract 90 1 7 20655123 10.1016/j.diabres.2010.06.021
19. Feng Y, Schlosser FJ, Sumpio BE: The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009, 50:675-82, 682 e1.
20. Y Feng FJ Schlosser BE Sumpio 2010 The Semmes Weinstein monofilament examination is a significant predictor of the risk of foot ulceration and amputation in patients with diabetes mellitus J Vasc Surg 53 220 226 20692793 10.1016/j.jvs.2010.06.100 e1-5
21. B Miranda-Palma JM Sosenko JH Bowke MS Mizel AJM Boulton 2005 A comparison of the monofilament with other testing modalities for foot ulcer susceptibility Diabetes Res Clin Pract 70 8 12 16126117 10.1016/j.diabres.2005. 02.013 1:STN:280:DC%2BD2MvlvVektw%3D%3D (Pubitemid 41207641)
22. BA Perkins A Orszag M Ngo E Ng P New V Bril 2010 Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study Diabetes Care 33 1549 1554 20357373 10.2337/dc09-1835 A recent prospective study showing that a scoring system of monofilament testing predicts development of neuropathy
23. J Booth MJ Young 2000 Differences in the performance of commercially available 10-g monofilaments Diabetes Care 23 984 988 10895851 10.2337/diacare.23.7.984 1:STN:280:DC%2BD3M%2FhtlGntg%3D%3D (Pubitemid 30480028)
24. RW Van Deursen MM Sanchez JA Derr MB Becker JS Ulbrecht PR Cavanagh 2001 Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability Diabet Med 18 469 475 11472466 10.1046/j.1464-5491.2001.00503.x (Pubitemid 32738696)
25. MJ Young JL Breddy A Veves AJ Boulton 1994 The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study Diabetes Care 17 557 560 8082524 10.2337/diacare.17.6.557 1:STN:280:DyaK2czmsVWmug%3D%3D (Pubitemid 24161977)
26. J Elliott S Tesfaye N Chaturvedi RA Gandhi LK Stevens C Emery, et al. 2009 Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors Diabetes Care 32 1896 1900 19587366 10.2337/dc09-0554 1:CAS:528:DC%2BD1MXhtlehs7bN
27. CL Martin BH Waberski R Pop-Busui PA Cleary S Catton JW Albers, et al. 2010 Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study Diabetes Care 33 2635 2641 20833868 10.2337/dc10-0616
28. M McGill L Molyneaux DK Yue 2005 Which diabetic patients should receive podiatry care? An objective analysis Intern Med J 35 451 456 16176466 10.1111/j.1445-5994.2005.00880.x 1:STN:280:DC%2BD2MrgsVykuw%3D%3D (Pubitemid 41161060)
29. AJ Boulton RA Malik JC Arezzo JM Sosenko 2004 Diabetic somatic neuropathies Diabetes Care 27 1458 1486 15161806 10.2337/diacare.27.6.1458 (Pubitemid 38680000)
30. A Veves HJ Murray MJ Young AJ Boulton 1992 The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study Diabetologia 35 660 663 1644245 10.1007/BF00400259 1:STN:280:DyaK38zlsVynsg%3D%3D
31. A Caselli H Pham JM Giurini DG Armstrong A Veves 2002 The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration Diabetes Care 25 1066 1071 12032116 10.2337/diacare.25.6.1066 (Pubitemid 41110495)
32. LA Lavery DG Armstrong RP Wunderlich JL Tredwell AJM Boulton 2003 Predictive value of foot pressure assessment as part of a population-based diabetes disease management program Diabetes Care 26 1069 1073 12663575 10.2337/diacare.26.4.1069 (Pubitemid 36929250)
33. JD England GS Gronseth G Franklin RG Miller AK Asbury GT Carter, et al. 2005 Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 64 199 207 15668414 10.1212/01.WNL.0000149522.32823.EA 1:STN:280:DC%2BD2M%2FktFSnsw%3D%3D
34. AL Carrington JE Shaw CH Van Schie CA Abbott L Vileikyte AJ Boulton 2002 Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25 2010 2015 12401748 10.2337/diacare.25.11.2010 (Pubitemid 41071060)
35. BA Perkins J Grewal E Ng M Ngo V Bril 2006 Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy Diabetes Care 29 2023 2027 16936147 10.2337/dc08-0500 (Pubitemid 44871181)
36. AI Vinik X Kong JT Megerian SN Gozani 2006 Diabetic nerve conduction abnormalities in the primary care setting Diabetes Technol Ther 8 654 662 17109597 10.1089/dia.2006.8.654 (Pubitemid 44871495)
37. N Papanas D Ziegler 2011 New diagnostic tests for diabetic distal symmetric polyneuropathy J Diabetes Complications 25 44 51 19896871 10.1016/j.jdiacomp.2009.09.006
38. AJM Boulton 2004 The diabetic foot: from art to science. The 18th Camillo Golgi lecture Diabetologia 47 1343 1353 15309286 10.1007/s00125-004-1463-y 1:STN:280:DC%2BD2cvgsVCksg%3D%3D (Pubitemid 39232418)
39. PA Low LM Benrud-Larson DM Sletten TL Opfer-Gehrking SD Weigand PC O'Brien, et al. 2004 Autonomic symptoms and diabetic neuropathy Diabetes Care 27 2942 2947 15562211 10.2337/diacare.27.12.2942 (Pubitemid 39565063)
40. VA Low P Sandroni RD Fealey PA Low 2006 Detection of small-fiber neuropathy by sudomotor testing Muscle Nerve 34 57 61 16718689 10.1002/mus.20551
41. N Tentolouris K Marinou P Kokotis A Karanti E Diakomopoulou N Katsilambros 2009 Sudomotor dysfunction is associated with foot ulceration in diabetes Diabet Med 26 302 305 19317826 10.1111/j.1464-5491.2009.02677.x 1:STN:280:DC%2BD1M3jtV2ltw%3D%3D This cross-sectional study showed that sudomotor dysfunction assessed by SSR is associated with foot ulceration in diabetes
42. PC Sun HD Lin SH Jao RC Chan MJ Kao CK Cheng 2008 Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet Diabet Med 25 413 418 18341593 10.1111/j.1464-5491.2008.02395.x 1:STN:280:DC%2BD1c3ivVShsQ%3D%3D (Pubitemid 351490114)
43. American Diabetes Association 1995 Standardized measures in diabetic neuropathy. Consensus statement Diabetes Care 18 59 78
44. S Liatis K Marinou N Tentolouris N Pagoni N Katsilambros 2007 Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus Diabet Med 24 1375 1380 17941862 10.1111/j.1464-5491.2007.02280.x 1:CAS:528:DC%2BD1cXhtVOqu74%3D (Pubitemid 350179435)
45. C Quattrini M Jeziorska M Tavakoli P Begum AJM Boulton RA Malik 2008 The Neuropad test: a visual indicator test for human diabetic neuropathy Diabetologia 51 1046 1050 18368386 10.1007/s00125-008-0987-y 1:STN:280:DC%2BD1c3osFSiuw%3D%3D
46. N Tentolouris V Achtsidis K Marinou N Katsilambros 2008 Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes Diabetes Care 31 236 237 18025406 10.2337/dc07-1942 The study showed that NEUROPAD™ testing can be safely performed by the patients at home with comparable results with health care providers (Pubitemid 351213327)
47. V Spallone R Morganti M Siampli T Fedele C D'Amato L Cacciotti, et al. 2009 Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy Diabet Med 26 686 692 19573117 10.1111/j.1464-5491.2009.02760.x 1:STN:280:DC%2BD1MvmtlCgtQ%3D%3D
48. ZA Kamenov JJ Petrova VG Christov 2010 Diagnosis of diabetic neuropathy using simple somatic and a new autonomic (neuropad) tests in the clinical practice Exp Clin Endocrinol Diabetes 118 226 233 20200815 10.1055/s-0030- 1247565 1:CAS:528:DC%2BC3cXlvValtbs%3D
49. N Papanas G Giassakis K Papatheodorou D Papazoglou C Monastiriotis D Christakidis, et al. 2007 Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study J Diabetes Complications 21 353 358 17967706 10.1016/j.jdiacomp.2006.08.003 (Pubitemid 47633240)
50. N Papanas K Papatheodorou D Papazoglou C Monastiriotis D Christakidis E Maltezos 2008 A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes Exp Clin Endocrinol Diabetes 116 135 138 18095233 10.1055/s-2007-984455 1:CAS:528:DC%2BD1cXjslCjtrY%3D (Pubitemid 351363386)
51. N Papanas K Papatheodorou D Papazoglou S Kotsiou E Maltezos 2010 A prospective study on the use of the Indicator Test Neuropad® for the Early Diagnosis of Peripheral Neuropathy in type 2 Diabetes Exp Clin Endocrinol Diabetes 119 122 125 20690070 10.1055/s-0030-1261934 This study demonstrated that an abnormal NEUROPAD™ testing at baseline was associated with development of clinical neuropathy over a 5-year period.
52. N Tentolouris C Voulgari S Liatis A Kokkinos I Eleftheriadou K Makrilakis, et al. 2010 Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ulceration in diabetes Diabetes Care 33 1112 1114 20150296 10.2337/dc09-2027 This cross-sectional study showed that an abnormal NEUROPAD™ response is associated with foot ulceration in diabetes and the results obtained by NEUROPAD™ testing are as informative as those obtained by other established tests used for the prediction of foot ulcers.
53. American Diabetes Association 2010 Standards of medical care in diabetes Diabetes Care 33 Suppl.1 S11 S61 10.2337/dc10-S011